[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cencora Inc (COR)

Cencora Inc (COR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Cencora Earnings Preview: What to Expect

With a market cap of $59.9 billion, Cencora, Inc. (COR) is a leading global pharmaceutical solutions organization dedicated to improving the lives of people and animals worldwide. By partnering with pharmaceutical innovators and healthcare providers, the company enables secure, reliable access to therapies and healthcare solutions while advancing healthier futures.

The Conshohocken, Pennsylvania-based company is slated to announce its fiscal Q3 2026 results before the market opens on Wednesday, Aug. 5. Ahead of the event, analysts forecast Cencora to report an adjusted EPS of $4.37, up 9.3% from $4 in the year-ago quarter. It has surpassed Wall Street's bottom-line estimates in...

Fundamentals

See More
  • Market Capitalization, $K 59,922,840
  • Shares Outstanding, K 194,561
  • Annual Sales, $ 321,333 M
  • Annual Income, $ 1,554 M
  • EBIT $ 4,536 M
  • EBITDA $ 5,604 M
  • 60-Month Beta 0.58
  • Price/Sales 0.18
  • Price/Cash Flow 13.72
  • Price/Book 16.09

Options Overview Details

View History
  • Implied Volatility 34.62% (+1.05%)
  • Historical Volatility 24.77%
  • IV Percentile 99%
  • IV Rank 97.03%
  • IV High 35.04% on 03/30/26
  • IV Low 20.80% on 08/27/25
  • Expected Move (DTE 34) 22.95 (7.45%)
  • Put/Call Vol Ratio 0.10
  • Today's Volume 318
  • Volume Avg (30-Day) 330
  • Put/Call OI Ratio 0.32
  • Today's Open Interest 13,416
  • Open Int (30-Day) 12,484
  • Expected Range 284.95 to 330.85

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $4.37
  • Number of Estimates 4
  • High Estimate $4.43
  • Low Estimate $4.34
  • Prior Year $4.00
  • Growth Rate Est. (year over year) +9.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
269.30 +14.33%
on 06/22/26
313.90 -1.91%
on 07/17/26
+30.81 (+11.12%)
since 06/17/26
3-Month
244.82 +25.77%
on 05/06/26
327.99 -6.13%
on 04/20/26
-19.66 (-6.00%)
since 04/17/26
52-Week
244.82 +25.77%
on 05/06/26
377.54 -18.45%
on 11/25/25
+13.52 (+4.59%)
since 07/17/25

Most Recent Stories

More News
Cencora Earnings Preview: What to Expect

Cencora is scheduled to release its third-quarter results next month, with analysts projecting single-digit earnings growth.

ABT : 100.68 (+1.87%)
XLV : 161.09 (-0.44%)
$SPX : 7,457.69 (-1.01%)
COR : 307.90 (-0.03%)
Health Insurance Providers Stocks Q1 In Review: Cencora (NYSE:COR) Vs Peers

Health Insurance Providers Stocks Q1 In Review: Cencora (NYSE:COR) Vs Peers

COR : 307.90 (-0.03%)
3 Market-Beating Stocks for Long-Term Investors

3 Market-Beating Stocks for Long-Term Investors

GOOGL : 346.77 (-2.17%)
COR : 307.90 (-0.03%)
AXP : 355.35 (-1.72%)
Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release

Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Third Quarter of Fiscal 2026 on Wednesday, August 5, 2026, prior to the opening of trading on the New York Stock Exchange....

COR : 307.90 (-0.03%)
2 Large-Cap Stocks Worth Your Attention and 1 We Brush Off

2 Large-Cap Stocks Worth Your Attention and 1 We Brush Off

COR : 307.90 (-0.03%)
FLEX : 119.25 (-1.54%)
CAH : 228.52 (-0.09%)
3 Big Reasons to Love Cencora (COR)

3 Big Reasons to Love Cencora (COR)

COR : 307.90 (-0.03%)
Cencora Announces Samantha Hammock as Chief Human Resources Officer

Silvana Battaglia to retire after distinguished 7-year tenure

COR : 307.90 (-0.03%)
Cardinal Health Stock: Is CAH Outperforming the Healthcare Sector?

Cardinal Health has outperformed the healthcare sector over the past year. Moreover, Wall Street analysts are strongly bullish on the stock.

XLV : 161.09 (-0.44%)
COR : 307.90 (-0.03%)
CAH : 228.52 (-0.09%)
Is Cencora Stock Underperforming the Nasdaq?

Cencora has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.

$NASX : 25,520.24 (-1.40%)
MCK : 841.39 (+0.01%)
COR : 307.90 (-0.03%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR

NEW YORK , June 4, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cencora, Inc. ("Cencora" or the "Company") (NYSE: COR). Such investors are advised to contact...

COR : 307.90 (-0.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa.

See More

Key Turning Points

3rd Resistance Point 319.89
2nd Resistance Point 316.89
1st Resistance Point 312.40
Last Price 307.90
1st Support Level 304.91
2nd Support Level 301.91
3rd Support Level 297.42

See More

52-Week High 377.54
Fibonacci 61.8% 326.84
Fibonacci 50% 311.18
Last Price 307.90
Fibonacci 38.2% 295.52
52-Week Low 244.82

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.